Yipinhong (300723.SZ) subsidiary obtains registration certificate for eltrombopag olamine dry suspension

Zhitong Finance APP News, Yipinhong (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Eltrombopag Olamine for Oral Suspension approved and issued by the National Medical Products Administration. The company's receipt of the registration certificate for Eltrombopag Olamine for Oral Suspension marks that the company has obtained the qualification to sell this specification of the drug in the domestic market, which will further enrich the company's product pipeline and product categories and enhance the company's core competitiveness.